Malaysian Genomics Resource Centre Bhd 2021 AR2
The report highlights Malaysian Genomics Resource Centre Berhad's transition and expansion into biopharmaceutical and healthcare services, including cancer immunotherapy and COVID-19 related diagnostic products, during the financial year ended June 30, 2021. Despite challenges from the COVID-19 pandemic, the company completed its new state-of-the-art cell laboratory in Kota Damansara, which is the first privately owned Biosafety Level 2 laboratory in Malaysia for solid cancer immunotherapy. Financially, the company recorded a revenue of RM1.78 million, driven primarily by genome sequencing and analysis services, and successfully raised funds through a private placement. The company also demonstrated its commitment to sustainability by aligning its operations with ten United Nations Sustainable Development Goals and implementing green initiatives like solar energy planning.
Company: Malaysian Genomics Resource Centre Bhd
Sector: Professional & technical services
Country: Malaysia
Year: 2021
Type: AR2
Pages: 128
Back to company
Malaysian Genomics Resource Centre Bhd
Annual Report
The report highlights Malaysian Genomics Resource Centre Berhad's transition and expansion into biopharmaceutical and healthcare services, including cancer immunotherapy and COVID-19 related diagnostic products, during the financial year ended June 30, 2021. Despite challenges from the COVID-19 pandemic, the company completed its new state-of-the-art cell laboratory in Kota Damansara, which is the first privately owned Biosafety Level 2 laboratory in Malaysia for solid cancer immunotherapy. Financially, the company recorded a revenue of RM1.78 million, driven primarily by genome sequencing and analysis services, and successfully raised funds through a private placement. The company also demonstrated its commitment to sustainability by aligning its operations with ten United Nations Sustainable Development Goals and implementing green initiatives like solar energy planning.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jul 1, 2020 - Jun 30, 2021
Fiscal Year
2021
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
No data available